NFH
ACHN

NEXT Financial Holdings’s Achillion Pharmaceuticals ACHN Stock Holding History

NEXT Financial Holdings’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2K Buy
+600
New +$1.47K ﹤0.01% 1518

Other funds holding ACHN

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

NEXT Financial Holdings's ACHN Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Achillion Pharmaceuticals (ACHN) in Q1 2019: 600 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1518 among its holdings.

110 funds tracked by Wall St. Rank hold ACHN as of Q1 2019.

  • NEXT Financial Holdings held 600 shares of Achillion Pharmaceuticals worth $2K as of Q1 2019.
  • Achillion Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
  • Achillion Pharmaceuticals made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1518 holding.
  • 110 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.